Meeting Banner
Abstract #1738

Quantitative MRI to assess portal hypertension in cirrhosis patients at 3T

Chris R Bradley1,2, Rob E Scott2, Eleanor F Cox1,2, Naaventhan Palaniyappan2, Indra Neil Guha2, Guruprasad P Aithal2, and Susan T Francis1,2

1Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom, 2NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom

We have previously validated MRI as a surrogate measure of Hepatic Venous Pressure Gradient (HVPG) at 1.5T using T1 relaxation time and splanchnic haemodynamics. Here, we explore the use of quantitative 3T MRI to assess portal hypertension. A strong correlation between HVPG and fat suppressed IR SE-EPI T1 (p<0.0001) and a correlation with superior mesenteric artery (SMA) velocity (p=0.02) was observed. MOLLI T1 showed a weak correlation with HVPG (p=0.11) compared with SE-EPI (p<0.001) in a matched patient subset. A fat suppressed IR SE-EPI T1 scheme and SMA velocity can be used as a surrogate for HVPG at 3T.

This abstract and the presentation materials are available to members only; a login is required.

Join Here